We previously observed that HER2 level in high HER2-expressing BT474 breast cancer cells was not affected by trastuzumab treatment in vitro, but HER2 was downregulated in BT474 mouse xenograft tumors treated with trastuzumab [25]. This evidence concerns the gene ERBB2 and breast carcinoma.